QQ客服 官方微博 反馈留言

	Predictors of long-term outcomes in patients treated with riociguat for pulmonary arterial hypertension: data from the PATENT-2 open-label, randomised, long-term extension trial
	Ghofrani, Hossein-Ardeschir; Grimminger, Friedrich; Gruenig, Ekkehard; Huang, Yigao; Jansa, Pavel; Jing, Zhi-Cheng; Kilpatrick, David; Langleben, David; Rosenkranz, Stephan; Menezes, Flavia
	2016
卷号	4期号:5页码:361-371
ISSN号	2213-2600
DOI	10.1016/S2213-2600(16)30019-4
URL标识	查看原文
收录类别	SCIE ; PUBMED
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/6383157
专题	中国医学科学院 北京协和医学院
推荐引用方式 GB/T 7714	Ghofrani, Hossein-Ardeschir,Grimminger, Friedrich,Gruenig, Ekkehard,et al. Predictors of long-term outcomes in patients treated with riociguat for pulmonary arterial hypertension: data from the PATENT-2 open-label, randomised, long-term extension trial[J],2016,4(5):361-371.
APA	Ghofrani, Hossein-Ardeschir.,Grimminger, Friedrich.,Gruenig, Ekkehard.,Huang, Yigao.,Jansa, Pavel.,...&Humbert, Marc.(2016).Predictors of long-term outcomes in patients treated with riociguat for pulmonary arterial hypertension: data from the PATENT-2 open-label, randomised, long-term extension trial.,4(5),361-371.
MLA	Ghofrani, Hossein-Ardeschir,et al."Predictors of long-term outcomes in patients treated with riociguat for pulmonary arterial hypertension: data from the PATENT-2 open-label, randomised, long-term extension trial".4.5(2016):361-371.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。